JMDC Inc.

4483.T
Health Information Services
2026/08/21 Updated
Market Cap: $1.4B (¥226.8B)
Stock Price: $21.79 (¥3,465)
Exchange Rate: 1 USD = ¥158.98

Issuance of Stock Acquisition Rights | Aiming for Mid- to Long-term Business Expansion and Talent Acquisition

JMD Corporation plans to issue a total of 4,350 stock acquisition rights on July 16, 2026, with a maximum of 654,000 shares to be delivered. The purpose is business expansion and talent acquisition, with exercise period from July 1, 2029, to July 31, 2035.

Importance:
Page Updated: June 25, 2026
IR Disclosure Date: June 25, 2026

Key Figures

  • Total stock acquisition rights: 6,540 (18th), 270 (19th), 70 (20th)
  • Number of shares to be delivered: Up to 654,000 shares (18th), 27,000 shares (19th), 7,000 shares (20th)
  • Exercise price: 1,200 JPY (18th), 1 JPY (19th and 20th)

AI要約

Purpose and Overview of the Stock Acquisition Rights Issuance

JMD Corporation will issue a total of 4,350 stock acquisition rights from the 18th to the 20th on July 16, 2026. These rights are expected to deliver up to 654,000 shares, aiming to support business expansion and attract and retain talented personnel. The 18th issuance involves 6,540 rights, the 19th involves 270 rights, and the 20th involves 70 rights. The exercise period is from July 1, 2029, to July 31, 2035.

Future Outlook and Impact on Shareholders

This issuance of stock acquisition rights is aimed at enhancing the company's mid- to long-term business stage and increasing profits, and the dilution of shares is considered reasonable. The exercise conditions include achieving a consolidated EBITDA exceeding 22 billion JPY in any of the fiscal years from March 2029 to March 2032. The company aims to improve performance and increase shareholder value.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

JMD Corporation

Company overview · Stock price · Financial data · All IR

View company page →